We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Loteprednol etabonate

Australian Public Assessment Report

AusPAR

AusPAR: Loteprednol etabonate [PDF, 775.31 KB]

AusPAR: Loteprednol etabonate [Word, 896.66 KB]

Attachment: Product Information: Loteprednol etabonate [PDF, 213.21 KB]

Attachment: Product Information: Loteprednol etabonate [Word, 211.18 KB]

Attachment: Extract from Clinical Evaluation Report: Loteprednol etabonate [PDF, 715.65 KB]

Attachment: Extract from Clinical Evaluation Report: Loteprednol etabonate [Word, 545.26 KB]

Device/Product Name

Lotemax

Active ingredients

Loteprednol etabonate

AusPAR Date

17 April 2014

Published

2 June 2014

Submission Number

PM-2012-03141-1-5

Submission Type

New chemical entity

Decision

Approved